Price Chart

Price Chart

Profile

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
URL http://www.theratech.com
Investor Relations URL https://www.theratech.com/investors/
HQ State/Province Québec
Sector Health Care
Industry Biotechnology
Equity Style Small Cap Core
Next Earnings Release N/A
Last Earnings Release Oct. 15, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
URL http://www.theratech.com
Investor Relations URL https://www.theratech.com/investors/
HQ State/Province Québec
Sector Health Care
Industry Biotechnology
Equity Style Small Cap Core
Next Earnings Release N/A
Last Earnings Release Oct. 15, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A